Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Biliary Tract Neoplasms × titanium silicide × Clear all

Phase

Status

Sponsor Class

OTHER 2 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Biliary Tract Neoplasms 1

Interventions

Gemcitabine 9 Cisplatin 7 S 1 (combination) 5 Oxaliplatin 2 titanium silicide 1 spartalizumab 1 pembrolizumab 1 pamiparib 1 World Health Organization oral rehydration solution 1 Temozolomide 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01815307 2018-05-16

Phase II Study of Gemcitabine Versus S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer

Kansai Hepatobiliary Oncology Group

Phase 2 Completed

Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡